Skip to main content

Optic Nerve Disorder News

Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes

TUESDAY, April 8, 2025 – For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published...

Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide

WEDNESDAY, Feb. 26, 2025 – For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according...

Ozempic, Wegovy Linked To Potential Vision Loss

MONDAY, Feb. 24, 2025 – People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve, a new study says....

Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic Neuropathy

TUESDAY, Jan. 14, 2025 – Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Eye Conditions